What is the Optimal Method for Steroid Delivery in the Treatment of Chronic Rhinosinusitis With Nasal Polyps?

Chronic rhinosinusitis (CRS) is a prevalent heterogeneous inflammatory disorder of the sinonasal mucosa affecting up to 12.5% of the global population. Clinically, CRS can be classified as either CRS without nasal polyp (CRSsNP) or CRS with nasal polyp (CRSwNP). Steroids remain the mainstay treatmen...

Full description

Saved in:
Bibliographic Details
Published inAllergy, asthma & immunology research Vol. 11; no. 4; pp. 443 - 445
Main Authors Hong, Seung-No, Kim, Dong-Young
Format Journal Article
LanguageEnglish
Published Korea (South) Korean Academy of Asthma, Allergy and Clinical Immunology 01.07.2019
The Korean Academy of Asthma, Allergy and Clinical Immunology; The Korean Academy of Pediatric Allergy and Respiratory Disease
대한천식알레르기학회
Subjects
Corticoids
Corticosteroids
Disease control
Inflammatory diseases
Mucosa
Nose
Physicians
Polyps
Rhinosinusitis
Steroid hormones
Steroids
내과학
Online AccessGet full text
ISSN2092-7355
2092-7363
DOI10.4168/aair.2019.11.4.443

Cover

Abstract Chronic rhinosinusitis (CRS) is a prevalent heterogeneous inflammatory disorder of the sinonasal mucosa affecting up to 12.5% of the global population. Clinically, CRS can be classified as either CRS without nasal polyp (CRSsNP) or CRS with nasal polyp (CRSwNP). Steroids remain the mainstay treatment options in the management of type 2 inflammatory sinonasal disease and are considered a key component of medical therapy. The multifactorial anti-inflammatory effects along with the potent anti-remodeling effect of corticosteroids are the most important reasons for the widespread use in the treatment of CRSwNP. Currently, there are other considerable ongoing studies to find out the optimal method of corticosteroid delivery to sinonasal mucosa in CRSwNP. There are various intranasal steroid delivery devices available to physicians now.
AbstractList KCI Citation Count: 0
Chronic rhinosinusitis (CRS) is a prevalent heterogeneous inflammatory disorder of the sinonasal mucosa affecting up to 12.5% of the global population. Clinically, CRS can be classified as either CRS without nasal polyp (CRSsNP) or CRS with nasal polyp (CRSwNP). Steroids remain the mainstay treatment options in the management of type 2 inflammatory sinonasal disease and are considered a key component of medical therapy. The multifactorial anti-inflammatory effects along with the potent anti-remodeling effect of corticosteroids are the most important reasons for the widespread use in the treatment of CRSwNP. Currently, there are other considerable ongoing studies to find out the optimal method of corticosteroid delivery to sinonasal mucosa in CRSwNP. There are various intranasal steroid delivery devices available to physicians now.
Author Hong, Seung-No
Kim, Dong-Young
AuthorAffiliation 2 Department of Otorhinolaryngology, Seoul National University College of Medicine, Seoul National University Hospital, Seoul, Korea
1 Department of Otorhinolaryngology, Seoul National University College of Medicine, Seoul Metropolitan Government-Seoul National University Boramae Medical Center, Seoul, Korea
AuthorAffiliation_xml – name: 2 Department of Otorhinolaryngology, Seoul National University College of Medicine, Seoul National University Hospital, Seoul, Korea
– name: 1 Department of Otorhinolaryngology, Seoul National University College of Medicine, Seoul Metropolitan Government-Seoul National University Boramae Medical Center, Seoul, Korea
Author_xml – sequence: 1
  givenname: Seung-No
  orcidid: 0000-0002-5759-9929
  surname: Hong
  fullname: Hong, Seung-No
  organization: Department of Otorhinolaryngology, Seoul National University College of Medicine, Seoul Metropolitan Government-Seoul National University Boramae Medical Center, Seoul, Korea
– sequence: 2
  givenname: Dong-Young
  orcidid: 0000-0002-4000-1011
  surname: Kim
  fullname: Kim, Dong-Young
  organization: Department of Otorhinolaryngology, Seoul National University College of Medicine, Seoul National University Hospital, Seoul, Korea
BackLink https://www.ncbi.nlm.nih.gov/pubmed/31172713$$D View this record in MEDLINE/PubMed
https://www.kci.go.kr/kciportal/ci/sereArticleSearch/ciSereArtiView.kci?sereArticleSearchBean.artiId=ART002481958$$DAccess content in National Research Foundation of Korea (NRF)
BookMark eNp9kstuEzEUhi1URC_0BVggS2zoIoPvzmxAVbhVKhSVoC4tx-Nh3M7YwfZUytvjSUoEXeDNseTv_8_F5xgc-OAtAC8wqhgW8zdau1gRhOsK44pVjNEn4IigmswkFfRgf-f8EJymdIvKoZgxwZ6BQ4qxJBLTIzDcdDpDl2DuLLxaZzfoHn6xuQsNbEOE37ONwTXwve3dvY0b6PwWXUar82B9hqGFiy4G7wy87pwPyfkxuVwsb1zu4FediuO30G_W6d1z8LTVfbKnD_EE_Pj4Ybn4PLu8-nSxOL-cGVqzPBMICaKRMRJZzPiclu4agXAzX5EWGaIJ5ZbWNVrp1khGVkKLQmLDuOSNRvQEnO18fWzVnXEqaLeNP4O6i-r8enmhuGCCElzYtzt2Pa4G25jSU9S9WscyirjZKv998a4rPvdKcC6lJMXg9YNBDL9Gm7IaXDK277W3YUyKEMaFpExMuV49Qm_DGH0ZRaGElEhyIgv18u-K9qX8-bUCkB1gYkgp2naPYKSm7VDTdqhpOxTGiqkyvyKaPxIZl3V2YerK9f-T_gbLWL8b
CitedBy_id crossref_primary_10_3390_pharmaceutics13020246
crossref_primary_10_3897_rrpharmacology_6_54570
Cites_doi 10.2500/ajr.2007.21.3047
10.1002/alr.22214
10.1016/j.jaci.2008.02.018
10.1016/j.jaci.2011.08.004
10.1016/j.jaci.2018.03.004
10.1016/j.anl.2010.03.005
10.4168/aair.2019.11.2.156
10.1002/alr.21172
10.1136/bmj.j1415
10.1177/1945892418810281
10.2500/ajra.2014.28.4026
10.4193/Rhino50E2
ContentType Journal Article
Copyright Copyright Korean Academy of Asthma, Allergy and Clinical Immunology Jul 2019
Copyright © 2019 The Korean Academy of Asthma, Allergy and Clinical Immunology • The Korean Academy of Pediatric Allergy and Respiratory Disease 2019 The Korean Academy of Asthma, Allergy and Clinical Immunology • The Korean Academy of Pediatric Allergy and Respiratory Disease
Copyright_xml – notice: Copyright Korean Academy of Asthma, Allergy and Clinical Immunology Jul 2019
– notice: Copyright © 2019 The Korean Academy of Asthma, Allergy and Clinical Immunology • The Korean Academy of Pediatric Allergy and Respiratory Disease 2019 The Korean Academy of Asthma, Allergy and Clinical Immunology • The Korean Academy of Pediatric Allergy and Respiratory Disease
DBID AAYXX
CITATION
NPM
7T5
7U7
C1K
H94
7X8
5PM
ACYCR
DOI 10.4168/aair.2019.11.4.443
DatabaseName CrossRef
PubMed
Immunology Abstracts
Toxicology Abstracts
Environmental Sciences and Pollution Management
AIDS and Cancer Research Abstracts
MEDLINE - Academic
PubMed Central (Full Participant titles)
Korean Citation Index
DatabaseTitle CrossRef
PubMed
AIDS and Cancer Research Abstracts
Immunology Abstracts
Toxicology Abstracts
Environmental Sciences and Pollution Management
MEDLINE - Academic
DatabaseTitleList
AIDS and Cancer Research Abstracts
Database_xml – sequence: 1
  dbid: NPM
  name: PubMed
  url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
DeliveryMethod fulltext_linktorsrc
Discipline Medicine
EISSN 2092-7363
EndPage 445
ExternalDocumentID oai_kci_go_kr_ARTI_5646321
PMC6557772
31172713
10_4168_aair_2019_11_4_443
Genre Editorial
Commentary
GrantInformation_xml – fundername: Seoul National University Hospital
  grantid: 03-2018-0030
– fundername: ;
  grantid: 03-2018-0030
GroupedDBID ---
5-W
53G
8JR
8XY
9ZL
AAKDD
AAYXX
ACPRK
ADBBV
ADRAZ
AFRAH
ALMA_UNASSIGNED_HOLDINGS
AOIJS
BAWUL
CITATION
C~G
DIK
DYU
E3Z
EF.
F5P
GX1
HYE
KQ8
M48
O5R
O5S
OK1
PGMZT
RPM
M~E
NPM
7T5
7U7
C1K
H94
7X8
5PM
ACYCR
OZF
ID FETCH-LOGICAL-c394t-60062a0cc70e14583443d601d8b2f0c2a235e3990bafc742b6a60e11c4575da03
IEDL.DBID M48
ISSN 2092-7355
IngestDate Tue Nov 21 21:33:09 EST 2023
Thu Aug 21 18:11:44 EDT 2025
Fri Jul 11 16:19:40 EDT 2025
Mon Jun 30 12:01:49 EDT 2025
Thu Jan 02 23:01:28 EST 2025
Thu Apr 24 23:09:24 EDT 2025
Fri Jul 04 01:06:57 EDT 2025
IsDoiOpenAccess true
IsOpenAccess true
IsPeerReviewed true
IsScholarly true
Issue 4
Language English
License This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (https://creativecommons.org/licenses/by-nc/4.0/) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.
LinkModel DirectLink
MergedId FETCHMERGED-LOGICAL-c394t-60062a0cc70e14583443d601d8b2f0c2a235e3990bafc742b6a60e11c4575da03
Notes SourceType-Scholarly Journals-1
content type line 14
ObjectType-Editorial-2
ObjectType-Commentary-1
content type line 23
ORCID 0000-0002-5759-9929
0000-0002-4000-1011
OpenAccessLink http://journals.scholarsportal.info/openUrl.xqy?doi=10.4168/aair.2019.11.4.443
PMID 31172713
PQID 2267707527
PQPubID 2048270
PageCount 3
ParticipantIDs nrf_kci_oai_kci_go_kr_ARTI_5646321
pubmedcentral_primary_oai_pubmedcentral_nih_gov_6557772
proquest_miscellaneous_2245673461
proquest_journals_2267707527
pubmed_primary_31172713
crossref_primary_10_4168_aair_2019_11_4_443
crossref_citationtrail_10_4168_aair_2019_11_4_443
PublicationCentury 2000
PublicationDate 2019-07-01
PublicationDateYYYYMMDD 2019-07-01
PublicationDate_xml – month: 07
  year: 2019
  text: 2019-07-01
  day: 01
PublicationDecade 2010
PublicationPlace Korea (South)
PublicationPlace_xml – name: Korea (South)
– name: Seoul
PublicationTitle Allergy, asthma & immunology research
PublicationTitleAlternate Allergy Asthma Immunol Res
PublicationYear 2019
Publisher Korean Academy of Asthma, Allergy and Clinical Immunology
The Korean Academy of Asthma, Allergy and Clinical Immunology; The Korean Academy of Pediatric Allergy and Respiratory Disease
대한천식알레르기학회
Publisher_xml – name: Korean Academy of Asthma, Allergy and Clinical Immunology
– name: The Korean Academy of Asthma, Allergy and Clinical Immunology; The Korean Academy of Pediatric Allergy and Respiratory Disease
– name: 대한천식알레르기학회
References Waljee (10.4168/aair.2019.11.4.443_ref8) 2017; 357
Bachert (10.4168/aair.2019.11.4.443_ref5) 2018; 141
Fokkens (10.4168/aair.2019.11.4.443_ref2) 2012; 50
Emanuel (10.4168/aair.2019.11.4.443_ref10) 2014; 28
Thomas (10.4168/aair.2019.11.4.443_ref11) 2013; 3
Sindwani (10.4168/aair.2019.11.4.443_ref12) 2019; 33
Lou (10.4168/aair.2019.11.4.443_ref3) 2018; 8
Takeda (10.4168/aair.2019.11.4.443_ref7) 2010; 37
Hamilos (10.4168/aair.2019.11.4.443_ref1) 2011; 128
Dubin (10.4168/aair.2019.11.4.443_ref6) 2007; 21
Van Bruaene (10.4168/aair.2019.11.4.443_ref4) 2008; 121
Zhang (10.4168/aair.2019.11.4.443_ref9) 2019; 11
References_xml – volume: 21
  start-page: 483
  year: 2007
  ident: 10.4168/aair.2019.11.4.443_ref6
  publication-title: Am J Rhinol
  doi: 10.2500/ajr.2007.21.3047
– volume: 8
  start-page: 1218
  year: 2018
  ident: 10.4168/aair.2019.11.4.443_ref3
  publication-title: Int Forum Allergy Rhinol
  doi: 10.1002/alr.22214
– volume: 121
  start-page: 1435
  year: 2008
  ident: 10.4168/aair.2019.11.4.443_ref4
  publication-title: J Allergy Clin Immunol
  doi: 10.1016/j.jaci.2008.02.018
– volume: 128
  start-page: 693
  year: 2011
  ident: 10.4168/aair.2019.11.4.443_ref1
  publication-title: J Allergy Clin Immunol
  doi: 10.1016/j.jaci.2011.08.004
– volume: 141
  start-page: 1543
  year: 2018
  ident: 10.4168/aair.2019.11.4.443_ref5
  publication-title: J Allergy Clin Immunol
  doi: 10.1016/j.jaci.2018.03.004
– volume: 37
  start-page: 700
  year: 2010
  ident: 10.4168/aair.2019.11.4.443_ref7
  publication-title: Auris Nasus Larynx
  doi: 10.1016/j.anl.2010.03.005
– volume: 11
  start-page: 482
  year: 2019
  ident: 10.4168/aair.2019.11.4.443_ref9
  publication-title: Allergy Asthma Immunol Res
  doi: 10.4168/aair.2019.11.2.156
– volume: 3
  start-page: 691
  year: 2013
  ident: 10.4168/aair.2019.11.4.443_ref11
  publication-title: Int Forum Allergy Rhinol
  doi: 10.1002/alr.21172
– volume: 357
  start-page: j1415
  year: 2017
  ident: 10.4168/aair.2019.11.4.443_ref8
  publication-title: BMJ
  doi: 10.1136/bmj.j1415
– volume: 33
  start-page: 69
  year: 2019
  ident: 10.4168/aair.2019.11.4.443_ref12
  publication-title: Am J Rhinol Allergy
  doi: 10.1177/1945892418810281
– volume: 28
  start-page: 117
  year: 2014
  ident: 10.4168/aair.2019.11.4.443_ref10
  publication-title: Am J Rhinol Allergy
  doi: 10.2500/ajra.2014.28.4026
– volume: 50
  start-page: 1
  year: 2012
  ident: 10.4168/aair.2019.11.4.443_ref2
  publication-title: Rhinology
  doi: 10.4193/Rhino50E2
SSID ssj0000314464
Score 2.1648226
Snippet Chronic rhinosinusitis (CRS) is a prevalent heterogeneous inflammatory disorder of the sinonasal mucosa affecting up to 12.5% of the global population....
KCI Citation Count: 0
SourceID nrf
pubmedcentral
proquest
pubmed
crossref
SourceType Open Website
Open Access Repository
Aggregation Database
Index Database
Enrichment Source
StartPage 443
SubjectTerms Corticoids
Corticosteroids
Disease control
Inflammatory diseases
Mucosa
Nose
Physicians
Polyps
Rhinosinusitis
Steroid hormones
Steroids
내과학
Title What is the Optimal Method for Steroid Delivery in the Treatment of Chronic Rhinosinusitis With Nasal Polyps?
URI https://www.ncbi.nlm.nih.gov/pubmed/31172713
https://www.proquest.com/docview/2267707527
https://www.proquest.com/docview/2245673461
https://pubmed.ncbi.nlm.nih.gov/PMC6557772
https://www.kci.go.kr/kciportal/ci/sereArticleSearch/ciSereArtiView.kci?sereArticleSearchBean.artiId=ART002481958
Volume 11
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
ispartofPNX Allergy, 2019, Asthma & Immunology Research, 11(4), , pp.443-445
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV3db9MwED9tQ5r2gsbnwsZkEG8oJYkdp32aEDANpA4EqxhPluM41FrnjKaV6H_PXT4qigYPPOUhZ8u6s32_n-58B_Ciic3kZRzyNOMhXnhFOMwLE6Yjg85I6FgaeuA8PpdnE_HhMr3cgr7dUafA-lZqR_2kJvPZ4OeP1QkeeMSvA4QTw1daO6rsGY_w_A_EQAi-DXeaeBGl8nVwv7mZObEfCjQn0QiBJfra9h3NX6bZg10ek4eP-Ybb2vbz8jZE-mdi5W-e6nQf7nYQk71u98Q92LL-PuyOuyD6A7imct3M1QyxH_uIV8Y1So-bTtIMISz7gqquXMHe2hklbayY843oRZ-TzqqSdUV12eep81Xt_JJyv2r21S2m7FzXOOOnara6qU8ewuT03cWbs7DruhAaPhKLUNKzSh0Zk0U2pqgqKqJA2lYM86SMTKITnlqENVGuS4PEOpdaomRsBCK_Qkf8Eez4ytsDYMbqtBSlsJYPRY5z5QiPbNIU2eKy0AHEvVKV6UqSU2eMmUJqQjZRZBNFNkGmooTCpQTwcj3mpi3I8U_p52grdWWcojra9P1eqau5QrbwXqVSSJ7EARz1plT9BlQIS7MM8VSSBfBs_RvPHgVUtLfVkmQQfmZcSJzicWv59Zr6jRNAtrEn1gK0ns0_3k2b-t4yTTMkPU_-e-Qh7JEW2qziI9hZzJf2KWKnRX6MrOHb5Lg5Fr8ASs4WQg
linkProvider Scholars Portal
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=What+is+the+Optimal+Method+for+Steroid+Delivery+in+the+Treatment+of+Chronic+Rhinosinusitis+With+Nasal+Polyps%3F&rft.jtitle=Allergy%2C+asthma+%26+immunology+research&rft.au=Hong%2C+Seung-No&rft.au=Kim%2C+Dong-Young&rft.date=2019-07-01&rft.pub=The+Korean+Academy+of+Asthma%2C+Allergy+and+Clinical+Immunology%3B+The+Korean+Academy+of+Pediatric+Allergy+and+Respiratory+Disease&rft.issn=2092-7355&rft.eissn=2092-7363&rft.volume=11&rft.issue=4&rft.spage=443&rft.epage=445&rft_id=info:doi/10.4168%2Faair.2019.11.4.443&rft_id=info%3Apmid%2F31172713&rft.externalDocID=PMC6557772
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=2092-7355&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=2092-7355&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=2092-7355&client=summon